• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchImpact Biomedical
    Picture of Impact Biomedical logo

    IBO — Impact Biomedical Share News

    $3.600.000.00%
    us flag iconLast trade - 00:00
    HealthcareMicro CapFalling Star
    • Market Cap
      $30.76m
    • Enterprise Value
      $35.32m
    • Revenue
      $0.03m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IBO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IBO Dividends
    • Brief: Impact BioMedical Announces 1 For 12.62 Reverse Stock Split To Pursue Completion Of Merger With Zoar

      11/09/2026 21:21
    • Brief: Impact Biomedical Says On July 21 Entered Debt Conversion Agreement With DSS

      28/07/2025 16:13
    • Brief: Dr Ashleys Limited And Impact Biomedical Inc. Announce Strategic Merger

      23/06/2025 12:52
    • Brief: Impact BioMedical Announces Issuance Of Canadian Patent For Linebacker Technology Targeting Inflammatory Disease

      15/10/2024 11:22
    • Brief: Impact Biomedical Inc. Announces Pricing Of Initial Public Offering

      16/09/2024 19:50

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.